Skip to main content
SpringerLink
Log in

Low Molecular Weight Heparin in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism: A Paradigm Change in Care

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anderson F, Wheeler H, Goldberg R, et al. A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;15:933.

    Google Scholar 

  2. U.S. Department of Health and Human Services. Vital and Health Statistics 1997;41-43.

  3. Simonneau G, Charbonnier B, Decousus H, et al. Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 1993;153:1541-1546.

    Google Scholar 

  4. Lindmarker P, Holmstrom M, Granqvist S, et al. Comparison of once daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1994;72:186-190.

    Google Scholar 

  5. de Valk H, Banga J, Wester J, et al. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med 1995;123:1.

    Google Scholar 

  6. Hull R, Raskob G, et al. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N Engl J Med 1992;326:975-982.

    Google Scholar 

  7. The Columbus Investigators. Low molecular weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-662.

    Google Scholar 

  8. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low molecular weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE study Group. N Engl J Med 1997;337:663-669.

    Google Scholar 

  9. Partsch H, Kechavarz B, Mostbeck A, et al. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once or twice daily low molecular weight heparin. J Vasc Surg 1996;24:774-782.

    Google Scholar 

  10. Merli GJ. Using LMWHs to treat acute DVT. Internal Medicine 1999;(Suppl):12-19.

    Google Scholar 

  11. Levine M, Gent M, Hirsh J, et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med 1996;334:667-681.

    Google Scholar 

  12. Koopman M, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996;334:682-687.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Internal Medicine, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, USA

    Geno J. Merli

Authors
  1. Geno J. Merli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merli, G.J. Low Molecular Weight Heparin in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism: A Paradigm Change in Care. J Thromb Thrombolysis 9 (Suppl 1), 21–27 (2000). https://doi.org/10.1023/A:1018756302725

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018756302725

Keywords

Search

Navigation